Philosophy of Care
Dr. Carr-Ascher is committed to providing comprehensive and innovative care for her patients. She believes that compassion, honesty, and shared decision making are the cornerstones of medical practice. Dr. Carr-Ascher focuses on treating the whole patient while providing high quality evidence based care.
Dr. Carr-Ascher is a medical oncologist providing care for adults with cancer. She has an expertise and clinical focus on sarcomas, tumors of connective tissue.
Dr. Carr-Ascher's research focuses on understanding the biology of sarcoma with the goal of identifying new treatment options. She is working to characterize new ways of studying sarcoma development and metastasis.
Hematology and Oncology
M.D., University of Illinois at Chicago, Chicago IL 2013
Ph.D., University of Illinois at Chicago, Chicago IL 2013
B.S., University of California San Diego, San Diego CA 2002
Internal Medicine, UC San Francisco, San Francisco CA 2013-2015
Hematology/Oncology, UC Los Angeles, Los Angeles CA 2015-2019
American Board of Internal Medicine,
American Society of Clinical Oncology
American Society of Hematology
Honors and Awards
Chief Fellow, UCLA Specialty Training and Advanced Research (STAR) program, 2018
Resident Teaching Award, 2017
UIC College of Medicine Research Forum Award, 2009
National Ruth Kirshstein Service Award, F31, National Cancer Institute, 2008, 2009, 2010, 2011
National Academy of Science Bridge to the Doctorate Fellow, 2005, 2006, 2007
Select Recent Publications
Mukhopadhyay NK, Chand V, Pandey A, Kopanja D, Carr JR, Chen Y, Liao X, Raychaudhuri P. Plk1 Regulates the Repressor Function of FoxM1b by Inhibiting its Interaction with the Retinoblastoma Protein. Scientific Reports. 2017 April;7(46017).
Kopanja D, Pandey A, Kiefer M, Wang Z, Chandan N, Carr JR, Franks R, Yu D, Guzman G, Maker A, Raychaudhuri P. Essential Roles of FoxM1 in Ras-Induced Liver Cancer Progression and in Cancer Cells with Stem Cell Features. Journal of Hepatology. 2015 Aug;63(2):429-436.
Wang Z, Zheng Y, Park HJ, Li J, Carr JR, Chen YJ, Kiefer MM, Kopanja D, Bagchi S, Tyner AL, Raychaudhuri, P. Targeting FoxM1 Effectively Retards p53-null Lymphoma and Sarcoma. Mol Cancer Therapy. 2013 Feb 20.
Carr JR, Kiefer MM, Park HJ, Li J, Wang Z, Fontanarosa J, DeWaal D, Kopanga D, Benevolenskya E, Guzman G, Raychaudhuri P. FoxM1 Regulates Mammary Luminal Cell Fate. Cell Reports. 2012 June;1(6):715-729.
Wang Z, Park HJ, Carr JR, Chen YJ, Zheng Y, Li J, Tyner AL, Costa RH, Bagchi S, Raychaudhuri P. FoxM1 in Tumorigenicity of the Neuroblastoma Cells and Renewal of the Neural Progenitors. Cancer Research. 2011 June;71(12):4292-302.
Park HJ, Gusarova G, Wang Z, Carr JR, Li J, Kim KH, Qiu J., Park YD, Williamson PR, Hay N, Tyner AL, Lau LF, Costa RH, Raychaudhuri P. Deregulation of FoxM1b Leads to Tumor Metastasis. EMBO Mol Med. 2011 Jan;3(1):2134.
Carr JR, Park HJ, Wang Z, Kiefer M, and Raychaudhuri P. FoxM1 Mediates Resistance to Herceptin and Paclitaxel. Cancer Research. 2010 June;70(12):5054-63.
Park H., Carr J., Wang Z., Nogueira V., Hay N., Tyner A., Lau L., Costa R., and Raychaudhuri P. FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO Journal. 2009 Oct;28(19):2908-18.
Oppegard S, Nam K, Carr J, Skaalure S, Eddington D. Modulating temporal and spatial oxygenation over adherent cellular cultures. PLOS Biology. 2009 Sept;4(9):e6891.